PT1229936E - USE OF ANTI-IDIOTIPIC ANTIBODIES AS A VACCINE AGAINST CANCER - Google Patents

USE OF ANTI-IDIOTIPIC ANTIBODIES AS A VACCINE AGAINST CANCER

Info

Publication number
PT1229936E
PT1229936E PT00987250T PT00987250T PT1229936E PT 1229936 E PT1229936 E PT 1229936E PT 00987250 T PT00987250 T PT 00987250T PT 00987250 T PT00987250 T PT 00987250T PT 1229936 E PT1229936 E PT 1229936E
Authority
PT
Portugal
Prior art keywords
vaccine against
against cancer
idiotipic
antibodies
idiotipic antibodies
Prior art date
Application number
PT00987250T
Other languages
Portuguese (pt)
Inventor
Hans Loibner
Helmut Eckert
Gottfried Himmler
Original Assignee
Igeneon Krebs Immuntherapie F
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Igeneon Krebs Immuntherapie F filed Critical Igeneon Krebs Immuntherapie F
Publication of PT1229936E publication Critical patent/PT1229936E/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/32—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against translation products of oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/06—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies from serum
    • C07K16/065—Purification, fragmentation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PT00987250T 1999-11-16 2000-11-15 USE OF ANTI-IDIOTIPIC ANTIBODIES AS A VACCINE AGAINST CANCER PT1229936E (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT0192799A AT409086B (en) 1999-11-16 1999-11-16 NEW USE OF ANTIBODIES AS VACCINE

Publications (1)

Publication Number Publication Date
PT1229936E true PT1229936E (en) 2004-09-30

Family

ID=3524036

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00987250T PT1229936E (en) 1999-11-16 2000-11-15 USE OF ANTI-IDIOTIPIC ANTIBODIES AS A VACCINE AGAINST CANCER

Country Status (24)

Country Link
EP (1) EP1229936B1 (en)
JP (1) JP2003514028A (en)
KR (1) KR20020060968A (en)
CN (1) CN1390138A (en)
AT (1) AT409086B (en)
AU (1) AU780853B2 (en)
BR (1) BR0015597A (en)
CA (1) CA2391927A1 (en)
CZ (1) CZ20021707A3 (en)
DE (1) DE50006526D1 (en)
DK (1) DK1229936T3 (en)
EE (1) EE200200252A (en)
ES (1) ES2218272T3 (en)
HU (1) HUP0204216A2 (en)
IL (1) IL149614A0 (en)
IS (1) IS6381A (en)
MX (1) MXPA02004942A (en)
NO (1) NO20022333L (en)
NZ (1) NZ518669A (en)
PL (1) PL356770A1 (en)
PT (1) PT1229936E (en)
SK (1) SK6542002A3 (en)
TR (1) TR200401267T4 (en)
WO (1) WO2001035989A2 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4017108A (en) * 1975-04-17 1977-04-12 Archibald Kenrick And Sons Limited Window stay
US6294171B2 (en) * 1999-09-14 2001-09-25 Milkhaus Laboratory, Inc. Methods for treating disease states comprising administration of low levels of antibodies
AT410172B (en) * 2000-03-21 2003-02-25 Igeneon Gmbh METHOD FOR PRODUCING VACCINE FORMULATION
AT410637B (en) * 2001-06-01 2003-06-25 Igeneon Krebs Immuntherapie USE OF POLYCLONAL IMMUNOGLOBULINES
AT502293B1 (en) * 2002-05-15 2008-03-15 Igeneon Krebs Immuntherapie IMMUNOGENERAL, MONOCLONAL ANTIBODY
AT500648B1 (en) * 2002-08-12 2010-03-15 Igeneon Krebs Immuntherapie SET FOR THE TREATMENT OF CANCER PATIENTS
KR100522526B1 (en) * 2002-11-28 2005-10-19 주식회사 바이넥스 Method of Preparing Dendritic cell for Immunotherapy
AT500650B1 (en) 2003-04-17 2009-11-15 Altropus Gmbh IMMUNOGENIC RECOMBINANT ANTIBODY
US20070048795A1 (en) * 2005-08-26 2007-03-01 Xiangming Fang Immunoaffinity separation and analysis compositions and methods
EP2044949A1 (en) 2007-10-05 2009-04-08 Immutep Use of recombinant lag-3 or the derivatives thereof for eliciting monocyte immune response
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
US20180008702A1 (en) * 2014-12-05 2018-01-11 Celltrion Inc. Adjuvant composition containing at least one influenza virus neutralizing and binding molecule and vaccine composition containing same
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0135536A1 (en) * 1983-01-28 1985-04-03 Centocor, Inc. Anti-idiotypic antibodies to t cell antigen receptors
DE68920016T2 (en) * 1988-05-17 1995-04-20 Soldano Ferrone ANTI-IDIOTYPE ANTIBODIES AGAINST ANTI-HUMAN HIGH MOLECULAR ANTIGENS ASSOCIATED WITH MELANOMAS.
US20030072751A1 (en) * 1990-03-14 2003-04-17 Heribert Bohlen Idiotypic vaccination against b cell lymphoma
IT1254315B (en) * 1992-03-27 1995-09-14 Mini Ricerca Scient Tecnolog ANTI-IDIOTYPIC MONOCLONAL ANTIBODIES DIRECT AGAINST ANTI-TNF ANTIBODIES.
MX9304089A (en) * 1992-07-08 1994-01-31 Schering Corp USE OF GM-CSF AS AN ADJUVANT VACCINE.
JPH10511846A (en) * 1994-12-28 1998-11-17 ユニバーシティ オブ ケンタッキー Recombinant monoclonal anti-idiotype antibody 3H1 sequence related to human carcinoembryonic antigen

Also Published As

Publication number Publication date
ATA192799A (en) 2001-10-15
EP1229936B1 (en) 2004-05-19
KR20020060968A (en) 2002-07-19
CN1390138A (en) 2003-01-08
ES2218272T3 (en) 2004-11-16
CA2391927A1 (en) 2001-05-25
MXPA02004942A (en) 2003-10-14
CZ20021707A3 (en) 2002-10-16
AU780853B2 (en) 2005-04-21
DE50006526D1 (en) 2004-06-24
SK6542002A3 (en) 2002-11-06
NO20022333L (en) 2002-06-03
AU2357201A (en) 2001-05-30
NZ518669A (en) 2003-08-29
NO20022333D0 (en) 2002-05-15
WO2001035989A2 (en) 2001-05-25
IL149614A0 (en) 2002-11-10
HUP0204216A2 (en) 2003-04-28
EP1229936A2 (en) 2002-08-14
BR0015597A (en) 2002-07-23
AT409086B (en) 2002-05-27
JP2003514028A (en) 2003-04-15
IS6381A (en) 2002-05-14
DK1229936T3 (en) 2004-08-30
EE200200252A (en) 2003-06-16
PL356770A1 (en) 2004-07-12
TR200401267T4 (en) 2004-07-21
WO2001035989A3 (en) 2001-10-04

Similar Documents

Publication Publication Date Title
DK1210113T3 (en) Combined vaccine preparations
BR0010113B1 (en) PREPARATIONS FOR EXTERNAL SKIN USE.
NO20014325D0 (en) Vaccine
CY2011008I2 (en) FLU VACCINE
DE60045324D1 (en) vaccine composition
ATE413188T1 (en) HUMAN PAPILLOMAVIRUS VACCINE FORMULATIONS
NO20021433L (en) vaccinations
DK1031346T3 (en) Non-invasive skin vaccination
DE60023971D1 (en) Disposable underwear
NO20031483D0 (en) Vaccine
NO20024172D0 (en) Vaccine
DE60002650D1 (en) Oil-vaccinated vaccine
NO20020763L (en) Vaccine
PT1173187E (en) COMBINED PREPARATIONS UNDERSTANDING ANTRACCYCLINE DERIVATIVES
PT1229936E (en) USE OF ANTI-IDIOTIPIC ANTIBODIES AS A VACCINE AGAINST CANCER
EE200200150A (en) Preparation
DE60028272D1 (en) Disposable underwear
DE60013608D1 (en) PACEMAKER
DE60016452D1 (en) PACEMAKER
DE50010675D1 (en) ROTOR BODY
DE50009295D1 (en) NETWORK-FREE PREPARATIONS
SI1229936T1 (en) Use of anti-idiotypical antibodies as vaccines against cancer
AR028262A1 (en) HUMAN FAP-ALFA SPECIFIC ANTIBODIES
ITCT990008V0 (en) ELECTROSTIMULATOR FOR AESTHETIC USE
DK1060749T3 (en) Aqueous pharmaceutical preparation containing Tezosentan